14 results
Common IV to PO Drug Conversions
1) Metoprolol 1:2.5
2) Diltiazem Oral Dose(mg/day) = [ rate (mg/hr) x
IV to PO Drug Conversions ... 2) Diltiazem Oral ... #Pharmacology # ... Common #Intravenous ... #Oral
Insulin Pharmacology and Conversion

 • Conversion of U-100 to U-500 Insulin
 • Inpatient Intravenous to subcutaneous
Insulin Pharmacology ... and Conversion ... • Conversion ... • Inpatient Intravenous ... DharSaty #Insulin #Pharmacology
Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients

Source Article:
Intervention With Intravenous ... dhcisewski #Opioid #Oral ... #Intervention #Intravenous ... #Pain #VisualAbstract
Iron - Possible Routes of Administration and Fate in the Organism

#Iron #Absorption #Routes #Pathophysiology #pharmacology #Oral
Pathophysiology #pharmacology ... #Oral #Intravenous
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... P2Y12 Inhibitors Oral ... Switching Between Intravenous ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
unique dosing conversions ... the equinalgesic oral ... #Pharmacology #Pain ... Opiate #Opioid #Conversion
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... cirrhosis) • Oral ... Equianalgesia Conversion ... #Pain #Opioid #Conversion ... #medications #pharmacology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Fondaparinux, and Novel Oral ... with parenteral (intravenous ... subcutaneous) and oral ... a traditional oral ... #Pharmacology #Pathophysiology
Acute Atrial Fibrillation - Initial Options for Rate Control
Diltiazem IV
 •  Rapid onset and rapidly
transition to oral ... control Diltiazem (Oral ... transition to oral ... ADHF • Risks conversion ... Rate #Control #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching Between Oral ... Switching between oral ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology